Susceptibilities of species of the Bacteroides fragilis group to 10 antimicrobial agents.
AUTOR(ES)
Betriu, C
RESUMO
A total of 94 clinical isolates of the Bacteroides fragilis group was tested for susceptibility to metronidazole, chloramphenicol, clindamycin, cefoxitin, cefotetan, cefmetazole, moxalactam, mezlocillin, amoxicillin-clavulanic acid, and imipenem. All the strains tested were susceptible to imipenem, metronidazole, amoxicillin-clavulanic acid, and chloramphenicol. The rate of resistance to clindamycin was 21%. The results of this study demonstrate a difference in resistance rates from one species of the B. fragilis group to another.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=171666Documentos Relacionados
- Susceptibilities of 394 Bacteroides fragilis, non-B. fragilis group Bacteroides species, and Fusobacterium species to newer antimicrobial agents.
- Susceptibilities of members of the Bacteroides fragilis group to 11 antimicrobial agents.
- In vitro susceptibilities of the Bacteroides fragilis group to 14 antimicrobial agents in Korea.
- Longitudinal study of susceptibilities of species of the Bacteroides fragilis group to five antimicrobial agents in three medical centers.
- In vitro susceptibilities of oral pigmented Bacteroides species to trospectomycin and other selected antimicrobial agents.
